The president of Danone Baby Nutrition (DBN) says European Food Safety Authority (EFSA) health claim assessment methodologies are threatening the reputation of the scientific peer-review process and sections of the medical fraternity.
John Gay, the executive director and CEO of the Washington DC-based Natural Product Association (NPA), commends industry for the lobbying effort that has led to Republican Senator John McCain agreeing to alter his highly unpopular Bill.
In this US regulatory round-up, New York-based food and drug attorney, Marc Ullman unpicks the reformed position of Republican Senator John McCain on the regulations governing dietary supplements.
The Food and Drug Administration and the European Food Safety Authority have similar criteria in place when it comes to evaluating health claim-backing evidence – both prefer human intervention trials.
Arizona Republican Senator, John McCain, has indicated he may withdraw support for the Bill he sponsored in February that would have severely amended the way the US dietary supplements industry is regulated.
Pomegranate leader Pom Wonderful has issued a statement about the warning letter it received from the Food and Drug Administration (FDA) regarding antioxidant-based health claims being made on two of its websites.
Cognis Nutrition and Health has joined fellow lutein supplier, Kemin Health, in committing to sending the European food science agency a reworked lutein dossier to support its eye health claims.
Texan omega-3 supplier Omega Protein Corporation says its offerings meet international regulatory requirements, including the strict contaminants rules set out in California’s Proposition 65.
By issuing warning letters to 17 companies including Nestle and Pom Wonderful, the Food and Drug Administration yesterday demonstrated it had both the motivation and the muscle to remove misleading nutrition and health claims from the market, a move industry...
The Food and Drug Administration has issued pomegranate juice market leader, Pom Wonderful, with a warning letter over antioxidant claims it says are unauthorized drug claims.
Groups representing fish oil suppliers have defended the safety record of the multi-billion dollar omega-3 source in the face of legal action mounted in a San Francisco court.
The Food and Drug Administration has told a Texas start-up its melatonin-containing beverage breaches the Federal Food, Drug, and Cosmetic Act because the nutrient associated with promoting sleep is not approved as a food additive.
An LA Times article drawing attention to FDA-approved labeling has stated that the FDA does not regulate, “vitamins, herbs or other dietary supplements”, and quoted an FDA official stating ‘health-promoting’ claims require no agency evaluation.
The world’s leading lutein suppliers should work together to build a winning eye health dossier, Indian player OmniActive Health Technologies has said after the European food science agency turned down a lutein-eye health claim on Thursday.
Food manufacturers aspiring to ethically sound practices should seek ingredient quality assurance, says US Pharmacopeia, the standards-setting authority behind the Food Chemicals Codex (FCC).
Leading dietary supplements trade group the Council for Responsible Nutrition (CRN) has sent a letter to Republican Senator John McCain addressing serious concerns it has about floor statements the Senator made on Monday which slammed dietary supplements...
Sara Lee has issued a clarification statement regarding its EarthGrain-brand bread after organic farming campaigners at Cornucopia accused it of “misleading and unethical” claims.
Republican Senator John McCain of Arizona has issued a statement criticizing “lobbyists” of falsely attacking the Dietary Supplement Safety Act of 2010 he introduced at the beginning of the month, which seeks to amend DSHEA in several fundamental ways.
The Food and Drug Administration (FDA) should consider an outright ban on front-of-pack labeling claims, say two nutrition experts in a Journal of the American Medical Association commentary.
In the final instalment in this series about antioxidants, NutraIngredients scans the regulatory landscape to see how the science backing the nutrient is being translated into law.
The fact the Federal Trade Commission (FTC) has issued warning letters to 11 companies over the marketing of omega-3 supplements is potentially concerning, says the Council for Responsible Nutrition (CRN), but the reasons the letters were sent require...
National public health association Health Canada has backed a report which recommends closer monitoring of adverse reactions to Herbal Medicinal Products (HMP).
The US dietary supplements industry has launched a fight back against Senator McCain’s proposed Dietary Supplement Safety Act (DSSA), which they say poses an unnecessary threat to existing legislation.
Californian authorities have issued an injunction against a supplements manufacturer in the state for marketing a hoodia gordonii extract-based appetite suppressant, after testing revealed it in fact contained no hoodia.
The Global Organization for EPA and DHA Omega-3s (GOED) wants interested parties to throw their support behind a campaign to establish omega-3 dietary reference intakes (DRI) in the US for the first time.
“The time has come for lawmakers to re-evaluate the DSHEA,” is the conclusion of a Johns Hopkins University School of Medicine academic in a recent report published in the Archives of Internal Medicine.
The recent Health Canada-issued conjugated linoleic acid (CLA) monograph is not perfect, but a great relief to suppliers of a nutrient that the agency came close to banning last summer.
More than four years after it first applied for a product license under Canada’s then-new Natural Health Products Directorate (NHPD), CLA player, Lipid Nutrition, is one company set to benefit from a monograph issued by the Canadian regulator that should...
The Food and Drug Administration has rejected suggestions that its enforcement action against companies which make false H1N1 claims for their health supplements relies too heavily on warning letters and fails to deter other companies from similar fraud.
Industry groups and legal experts have condemned the Dietary Supplement Safety Act of 2010 as an unnecessary threat to existing legislation that is already empowered to ensure dietary supplements in the United States are safe.
The Kellogg Company has dismissed a class action lawsuit filed against it in relation to health claims on one of its leading breakfast cereal products, Nutri-Grain bars.
A US District Court has ruled that no dry form of maltitol from Yucheng Lujian Biological Co. or its associated companies may enter the US, in the latest chapter of a patent dispute filed by French firm Roquette.
The Food and Drug Administration’s recently issued draft guidance on the difference between liquid supplements and beverages is confusing and may create a slippery slope of inappropriate criteria and mis-categorized products, according to the Council...
Australia’s Therapeutic Goods Administration (TGA) is reviewing the status of the weight loss product, Hydroxycut, which has been linked to liver problems.
Vitamin B and kava kava-bearing products being sold in products manufactured under different brand names but ostensibly being the same product should not be consumed, Health Canada has said, due to lack of market authorization.
A chewing gum marketed for its ability to enhance the male libido is being falsely marketed as a dietary supplement when it has the characteristics of a drug, according to New York food attorney, Marc Ullman.
Several American Herbal Products Association (AHPA) and American Botanical Council (ABC) members have been contacted by the Government Accountability Office (GAO) seeking information about the marketing of herbal products with an emphasis on new dietary...
The National Advertising Division of the Council of Better Business Bureaus (NAD) has told a CoQ10 supplements manufacturer to alter its marketing including a claim that the supplement in question could be 600 percent more effective than standard powders.
The parties suing the FDA over its qualified health claims system have filed opposition to the FDA’s own opposition to their suit that accuses the regulator of health claim censorship and distortion of scientific data.
In a world with a chronic ‘globesity’ problem spreading beyond western shores to places like India and China, products that promise to help individuals manage their weight via calorie control, fat burning, satiety, or some other mechanism, enjoy rampant...
Texan supplements manufacturer, Mannatech has settled a patent dispute with two companies that will see the companies pay $250,000 and cease making the glyconutrient products that infringed Mannatech’s patents.
Fuji Health Science, the American subsidiary of Japanese supplier, Fuji Chemical Industry, has won a GRAS (generally recognized as safe) thumb’s up from the FDA for its astaxanthin form – AstaREAL.
The American Herbal Products Association (AHPA) has pointed out that a recent report from Health Canada highlighting purported black cohosh adverse events, is actually a good thing for the industry.
Consuming beverages sweetened with non-nutritive sweeteners may lead to an increase in food consumption, and contribute to weight gain, says a new study from Purdue University.
The Food and Drug Administration’s (FDA) apparent reluctance to take decisive action is failing to protect consumers against false H1N1 claims made for health supplements, claims a leading US lawyer.
Health Canada is “monitoring the situation” after four of six black cohosh supplement products were found to contain related herbs, but not black cohosh itself.
The recent federal district court ruling that has ordered a company to pay $2m to the Federal Trade Commisssion (FTC) for making misleading weight loss claims will act as “road map” in the sector, according to a veteran claims attorney.
The Food and Drug Administration’s commitment to greater transparency is bearing fruit in the dietary supplements area, with the availability of GMP 483 reports providing valuable insights into potential GMP pitfalls.
